June 6, 2017August 24, 2022
University of Michigan Researchers Identify 16 New Genetic Markers That Shed Light on Psoriasis
News
University of Michigan researchers have shed more light on the genetic landscape behind the intricate mechanisms of psoriasis. The 16 ... Read more
June 1, 2017
OWCP and mediq Collaborate to Introduce Cannabinoid-based Psoriasis Cream in Germany
News
One World Cannabis Pharmaceutical Research (OWCP) and mediq Innovation Experts have partnered to introduce OWCP’s cannabinoid-based topical psoriasis cream in Germany. ... Read more
May 30, 2017May 30, 2017
FDA Approves BLA Filing for Sun Pharma’s Lead Candidate Therapy Tildrakizumab to Treat Plaque Psoriasis
News
The U.S. Food and Drug Administration (FDA) has accepted a Biologics License Application (BLA) for Sun Pharmaceutical’s lead investigational drug tildrakizumab ... Read more
May 25, 2017May 25, 2017
Janssen’s Phase 3 Trials for Guselkumab to Focus on Plaque Psoriasis, Psoriatic Arthritis
News
Janssen announced two new Phase 3 clinical trials for psoriasis for its investigational drug guselkumab. The company intends to explore ... Read more
May 23, 2017
Remicade Can Be Substituted for Less Expensive Biosimilar CT-P13, Clinical Trial Suggests
News
Patients taking Remicade (infliximab) can safely switch to treatment with biosimilar CT-P13, sold as Pfizer’s Inflectra and Celltrion Healthcare’s Remsima, according to ... Read more
May 16, 2017May 16, 2017
Cannabinoids Have Potential to Treat Skin Conditions Like Psoriasis, Review Shows
News
Compounds extracted from the cannabis plant (cannabinoids) have therapeutic proprieties that could be used to treat several skin conditions, including psoriasis, ... Read more
May 11, 2017
Phase 2b Trial of Psoriasis Therapy Prurisol Reaches 70% of Participant Target
News
An already started Phase 2b clinical trial of Prurisol as a treatment for moderate-to-severe chronic plaque psoriasis has recruited more than 70 ... Read more
May 9, 2017
Pfizer’s Xeljanz Reduced Nail Psoriasis in Phase 3 Trials of Plaque Disease
News
Pfizer’s rheumatoid arthritis drug Xeljanz (tofacitinib) was effective against nail psoriasis in patients with plaque disease, according to data from ... Read more
May 4, 2017May 4, 2017
FDA Accepts Pfizer’s Supplemental New Drug Application for Xeljanz to Treat Active Psoriatic Arthritis Patients
News
The U.S. Food and Drug Administration (FDA) will review Pfizer’s medication Xeljanz (tofacitinib citrate) 5 mg twice daily, to treat adults with ... Read more
May 2, 2017
Cimzia and Cosentyx Approved to Treat Active Psoriatic Arthritis in England and Wales
News
The U.K.’s National Institute for Health and Care Excellence (NICE) has approved the use of Cimzia (certolizumab pegol) and Cosentyx (secukinumab), ... Read more
April 27, 2017April 27, 2017
Valeant Prices Plaque Psoriasis Treatment, Siliq, at $3,500 a Month
News
Siliq (brodalumab) injection, recently approved to treat adults with severe plaque psoriasis, will be available in the U.S. at a ... Read more
April 20, 2017April 20, 2017
XTRAC Light Therapy Effectively Treats Psoriasis Lesions Without the Serious Side Effects of Rival Therapies, Says Strata
News
XTRAC targeted-light therapy safely treats skin lesions in psoriasis patients without the serious side effects linked to Humira and other conventional psoriasis drugs, ... Read more

September 22, 2016

Inaugural Psoriatic Arthritis Awareness Day Stresses Early Diagnosis, Treatment

News

Celgene Corporation and the National Psoriasis Foundation (NPF) have joined efforts to designate Sept. 28 as the inaugural Psoriatic Arthritis Awareness Day, a day dedicated to spreading the word about ... Read more

September 22, 2016September 27, 2016

Anti-inflammatory Recipe: Curry Chicken Salad

Social Clips

When you have psoriasis it is important to eat a diet rich in anti-inflammatory properties and antioxidants. This recipe for curry chicken salad is loaded with fruits and vegetables and it is rich in antioxidants. ... Read more

September 20, 2016

Treating Psoriatic Dactylitis with TNF-Alpha Inhibitors Like Remicade Improves Symptoms, Report Shows

News

New research suggests that symptoms of psoriatic dactylitis, a manifestation of psoriatic arthritis (PsA), can be improved with therapies that promote the inhibition of TNF-alpha, one of the most important molecular players ... Read more

September 15, 2016

Can-Fite’s Patent Application for Psoriasis Therapy Candidate Accepted in Europe

News

Can-Fite BioPharma has received a notice of allowance from the European Patent Office (EPO) accepting the patent application for the company’s new psoriasis treatment Piclidenoson (CF101). Piclidenoson is a novel adenosine ... Read more

September 13, 2016

Psoriatic Arthritis Patients’ Symptoms Improved with Otezla Treatments

News

Results from a Phase III clinical trial showed that treatment with Otezla (apremilast) led to clinical improvements in patients with psoriatic arthritis for up to 13 months, including signs and symptoms, ... Read more

September 8, 2016September 8, 2016

Vigorous Regular Exercise Can Lower Risk of Psoriasis, Study Finds

News

The importance of exercise has been emphasized in recent years, as researchers find more and more evidence that physical activity helps to prevent illness and improve general health. These benefits appear to extend to ... Read more

September 7, 2016September 7, 2016

Erelzi, Biosimilar to Enbrel, Approve to Treat Certain Psoriasis Patients

News

The U.S. Food and Drug Administration has approved Erelzi (etanercept-szzs), a biosimilar to the already licensed drug Enbrel (etanercept), for the treatment of multiple inflammatory diseases, including psoriasis. Erelzi may be used as ... Read more

September 2, 2016September 2, 2016

Taltz Seen as Effective Treatment for Psoriasis Arthritis in Phase 3 Trial

News

Results from a Phase 3 registered clinical trial have demonstrated that Taltz (ixekizumab) improves disease activity and physical function in patients with psoriasis arthritis. The study, “Ixekizumab, an interleukin-17A specific monoclonal antibody, ... Read more

University of Michigan Researchers Identify 16 New Genetic Markers That Shed Light on Psoriasis

OWCP and mediq Collaborate to Introduce Cannabinoid-based Psoriasis Cream in Germany

FDA Approves BLA Filing for Sun Pharma’s Lead Candidate Therapy Tildrakizumab to Treat Plaque Psoriasis

Janssen’s Phase 3 Trials for Guselkumab to Focus on Plaque Psoriasis, Psoriatic Arthritis

Remicade Can Be Substituted for Less Expensive Biosimilar CT-P13, Clinical Trial Suggests

Cannabinoids Have Potential to Treat Skin Conditions Like Psoriasis, Review Shows

Phase 2b Trial of Psoriasis Therapy Prurisol Reaches 70% of Participant Target

Pfizer’s Xeljanz Reduced Nail Psoriasis in Phase 3 Trials of Plaque Disease

FDA Accepts Pfizer’s Supplemental New Drug Application for Xeljanz to Treat Active Psoriatic Arthritis Patients

Cimzia and Cosentyx Approved to Treat Active Psoriatic Arthritis in England and Wales

Valeant Prices Plaque Psoriasis Treatment, Siliq, at $3,500 a Month

XTRAC Light Therapy Effectively Treats Psoriasis Lesions Without the Serious Side Effects of Rival Therapies, Says Strata